This week marks the start of the diabetes research reporting season, as the ADA Scientific Sessions began yesterday in San Diego. This is the number 1 go-to conference for new research and products focused on improving patient care. Our Medical  Editor, Joy Pape, and Publisher, Steve Freed, are there to …

New study shows lower risk for poor cardiovascular outcomes for T2 patients on glucagonlike peptide-1 receptor agonists.

Recent studies focus on increase in hunger, conclude diet drinks possibly cause an increase in blood sugars.

One long-acting insulin may be better at controlling glycemic variations.

In addition to psychosocial risk factors, disease related factors may also be contributing to bulimic symptoms.

Placing newborns in prospective studies to conduct genetic screenings with follow up may reduce the risk of DKA at diagnosis of type 1.

After 30 years of follow-up studies, DCCT/EDIC study gives findings regarding risk of severe hypoglycemia.

According to the Centers for Disease Control and Prevention, what percentage of patients who have diabetes and are older than 65 years old will die of heart disease? A. 58% B. 68% C. 78% D. 88% Follow the link to see the correct answer.

Diabetes in Control speaks with top endocrinologists and other medical professionals to bring you the latest in diabetes news and research. This week, we have a special interview with one of the presenters at the AACE 26th Annual Scientific & Clinical Congress in Austin, Texas. Dr. Weir discusses the pros and cons of SGLT-2 inhibitors in clinical practice.

Approximately what percentage of type 2 patients do you have on SGLT-2 Inhibitors? 1. None 2. 5% 3. 10% 4. 15% 5. 20% or greater Follow the link to see how you and your colleagues compare!